Multiplexed Diagnostics Market 2025-2029
The multiplexed diagnostics market is forecasted to grow by USD 14322.2 mn during 2024-2029, accelerating at a CAGR of 14.9% during the forecast period. The report on the multiplexed diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of infectious and chronic diseases, demand for rapid, accurate, and high-throughput testing, and growing focus on personalized and precision medicine.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's multiplexed diagnostics market is segmented as below:
By Product
- Kits and reagents
- Instruments and accessories
By Application
- Infectious disease
- Oncology
- Autoimmune diseases
- Cardiac diseases
- Others
By End-user
- Diagnostic labs
- Hospitals
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the introduction of new products as one of the prime reasons driving the multiplexed diagnostics market growth during the next few years. Also, strategic partnerships and collaborations and growth in point-of-care testing will lead to sizable demand in the market.
The report on the multiplexed diagnostics market covers the following areas:
- Multiplexed Diagnostics Market sizing
- Multiplexed Diagnostics Market forecast
- Multiplexed Diagnostics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading multiplexed diagnostics market vendors that include Abcam plc, Agena Bioscience Inc., Agilent Technologies Inc., Akonni Biosystems Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Chembio Diagnostics Inc., ChromaCode Inc, Co Diagnostics Inc, DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Illumina Inc., Meso Scale Diagnostics LLC, QIAGEN N.V., Quansys Biosciences Inc, Seegene Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc.. Also, the multiplexed diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.